Clinical Trial Update: A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs) [Phase 2]

View source ↗

Summary

Phase 2 randomized trial assessing maintenance systemic therapy after radiation for oligometastatic renal cell carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Oligometastatic Renal Cell Carcinoma | Phase 2 | Status: RECRUITING